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Abstract: The epidemiological evidence demonstrating the effect of disinfection by-products (DBPs)
from drinking water on colon and rectal cancers is well documented. However, no systematic
assessment has been conducted to assess the potential effect measure modification (EMM) in the
relationship between DBPs and cancer. The objective of this paper is to conduct a systematic literature
review to determine the extent to which EMM has been assessed in the relationship between DBPs
in drinking water in past epidemiological studies. Selected articles (n = 19) were reviewed, and
effect estimates and covariates that could have been used in an EMM assessment were gathered.
Approximately half of the studies assess EMM (n = 10), but the majority of studies only estimate
it relative to sex subgroups (n = 6 for bladder cancer and n = 2 both for rectal and colon cancers).
Although EMM is rarely assessed, several variables that could have a potential modification effect are
routinely collected in these studies, such as socioeconomic status or age. The role of environmental
exposures through drinking water can play an important role and contribute to cancer disparities.
We encourage a systematic use of subgroup analysis to understand which populations or territories
are more vulnerable to the health impacts of DBPs.
Keywords: THMs; cancer; effect measure modification; drinking water
1. Introduction
Disinfection is widely used for drinking water treatment to inactivate pathogens and to prevent
waterborne diseases. This process can produce disinfection by-products (DBPs), which result from
a chemical reaction between disinfectants such as chlorine and organic or inorganic matter in the
water [1]. Among the various DBPs (>600) [2], trihalomethanes (THMs) are the most studied due to
their relatively high prevalence and concentration in drinking water.
Numerous studies assess the association between exposure to chlorinated water and diverse
health outcomes. Some of them investigate the influence of chlorinated water or THMs on reproductive
health, such as small for gestational age [3,4], stillbirth, and low birth rate [3,5]. However, the majority
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of epidemiological studies investigate the impact of such water quality exposure on cancer outcomes.
Epidemiological studies have shown that DBP exposure through drinking water is associated
particularly with some types of cancer, namely, colon, rectal, and bladder [2,6–8], though contrasting
results for colon and rectal cancers have been found [6]. Reviews revealing a consistent association
between long-term exposure to THMs and risk of bladder cancer have been published in recent
years [8–10]. Additionally, several epidemiological studies found other risk factors for colon, rectal,
and bladder cancer, such as tobacco consumption [11–15], and dietary and genetic factors [13,16–21].
Other potential risk factors include urban residence [13,22] and alcohol consumption [13,16]. The
duration of exposure is also associated with an increasing risk of bladder cancer [7].
In a pooled analysis published in 2004, it was observed that the effect of THMs on bladder
cancer risk was more pronounced in men than women [23]. Several explanations were discussed,
including residual confounding and biological plausibility such as sex differences in metabolizing
DBPs. A proposed mechanism to explain this difference is the role of sex hormones in the modulation of
enzymes that metabolize chlorination by-products (for chloroform and brominated THMs) into reactive
metabolites. Other possible explanations are anatomic differences or variation in voiding frequency
between men and women, which can influence the action of DBPs as hormone disruptors [23].
To our knowledge, besides the study described above, no systematic review has attempted to
synthesize the literature that directly evaluates potential effect measure modifiers other than sex in
the association between disinfection by-products in drinking water and cancer. Yet, several other
potential effect measure modifiers such as socio-economic status could be particularly relevant to
shaping policies that target vulnerable populations or territories and aim to reduce inequalities in
cancer risks. This could help frame interventions to target specific subgroups and ensure exposure of
DBPs, such as THMs and HAAs, are below harmful levels. Such assessments for populations that are
unfairly treated in regard to their environmental exposures are relevant to the field of environmental
justice, which has drawn recent attention with important concerns about other water contaminants
such as with lead exposure in the Flint crisis [24]. In addition, these assessments can identify which
populations and territories are more vulnerable to the harmful effects of exposure to THMs and inform
interventions to reduce health disparities.
The literature in relation to environmental health inequalities emerged during these last two
decades and distinguishes two types of environmental inequalities: (i) inequalities related to the level of
exposure and (ii) inequalities related to the level of vulnerability (when the effect of an environmental
exposure is modified according to different sub-groups strata of the population) [25–28].
Findings from studies investigating differential exposure have shown that deprived populations
can be more exposed to contaminants in drinking water [5,24,29–35]. Among the few studies
dedicated to the analysis of environmental inequalities associated with DBPs, all focus on inequalities
related to the level of exposure, and show contrasting results. Briggs et al. [36] found a positive
association between levels of THMs in drinking water and an index of multiple deprivation. Inversely,
Delpla et al. [32] showed that municipalities with a lower material deprivation index have a lower
risk of elevated THMs levels at their tap. Evans et al. [33] and Vrijheid et al. [35] found no significant
relationships between individuals or community deprivation and THM concentrations in drinking
water. The absence of an association could be linked to one or more of the following: geographical
size of a study that could attenuate the associations when extending the studied area [36], lower
participation among people of lower education, type of exposure studied, location of both the early-life
and current residence of the person, and/or type of socio-economic indicator chosen [35].
This review focuses on differential vulnerability, which refers to the notion of “effect measure
modification” in epidemiology. This concept of vulnerability can be defined as a “greater likelihood
of an adverse outcome given a specific exposure, compared with the general population, including
both host (individual) and environmental (contextual) factors” [37]. We will focus this review on
socioeconomic status (SES) variables, but we will also consider potential vulnerability factors as
sex/gender and health behaviors.
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Differences in health opportunities and resources related to social class, race, and geographic
area can lead to a lower health status for vulnerable groups [38]. For example, it has been shown
in the last decade that that neighborhood SES can modify the effect of air pollutants [38,39] on
mortality. Such evidence has been used to provide recommendations towards interventions aimed
at specific low SES areas to reduce inequalities in mortality [40]. Understanding the effect measure
modification (EMM) in the health impacts of DBPs will be useful in shaping policies to reduce cancer
inequalities through proportionated interventions aimed at reducing exposure to DBPs. Yet, some
drinking water distribution systems may span large geographic areas and serve large and diverse
populations, so interventions on the distribution systems may be insufficient. In such a case, targeted
local interventions in the infrastructure or through awareness campaigns may be relevant.
The overall objectives of this paper are to synthetize the literature studying the role of EMM in
the relationship between DBPs in drinking water and cancer, and understand the extent to which it
has been assessed in past epidemiological studies. If this epidemiological information is available
in existing publications, this review will allow us to report the epidemiological evidence on the
differential vulnerability of DBPs to cancer risk. If epidemiological information is lacking on this
topic, the review will serve to highlight the knowledge gap and motivate future studies in this area.
Two successive stages are performed: (i) An updated systematic review is conducted on studies
measuring the association between DBPs in drinking water and colorectal and bladder cancers and
(ii) The presence of EMM is evaluated according to socio-demographic characteristics and individual
behaviors considered in the identified studies.
2. Materials and Methods
2.1. Search Strategy
We aim to identify all epidemiological studies investigating the effects of DBPs in drinking water
on colorectal and bladder cancers published in English in scientific journals between January 1975 and
August 2015. The strategy used to conduct this review, in accordance with the PRISMA guidelines [41],
consisted of grouping keywords that represented (i) the exposure (namely DBPs in drinking water)
and (ii) the health outcomes (namely, colon and rectal cancer (CRC) and bladder cancer). Keywords,
titles, and abstracts were searched in PubMed and Elsevier Embase on the Ovid SP portal and Web of
Science. There was no restriction on geographical location.
The keywords used for the literature search are as follows: (Disinfection by-products OR
Disinfection-by-products OR water disinfection OR chlorination by-products OR water chlorination
OR trichloromethane OR chloroform OR bromoform OR tribromomethane OR dichlorobromomethane
OR dibromochloromethane OR THM OR Haloacetic acids) AND (colorectal cancer OR colorectal
neoplasm OR colon cancer OR rectal cancer OR bladder cancer OR CRC).
Terms describing EMM were not included at this stage to avoid being too restrictive. Instead,
we appraised the EMM assessment during the data extraction process (see below). We did not include
keywords related to study design at this stage, but instead assessed this question while selecting
studies (see below).
2.2. Selection of Studies
In the first stage, the first two authors of this paper read and screened the abstract of each
returned article.
Papers meeting the following criteria were excluded from our review:
• Commentaries, editorials, review articles, or meta-analysis
• Studies not performed on human populations
• Studies not published in English
• Studies not including DBPs in drinking water or chlorinated water as the exposure
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• Qualitative studies
When reviewers disagreed about whether a study should be excluded, the two met in person to
discuss until an agreement was reached.
In a second stage, papers selected in the previous stage were fully screened and then excluded
according to the following criteria:
• Studies not reporting a quantitative estimate between DBPs in drinking water or chlorinated
waters and colorectal cancer or bladder cancer
• Studies not including colorectal cancer and/or bladder cancer as health outcomes
• Studies using an ecological design or only a spatial analysis
In addition, the reference section of studies identified was searched, and relevant references that
were not initially identified were added.
2.3. Data Extraction
Selected articles were reviewed separately by the first two researchers, and each documented
the first author, location, date of publication, sample size, study design (case-control, cohort study or
case-cohort), exposure measurement, health outcomes assessed, effect size and CI (Confidence Interval),
whether they included EMM assessment, and which subgroup was included in this assessment.
Finally, among studies that did not include an assessment of EMM, collected variables (i.e., those
presented in the sample description used as confounders) that could potentially be used for an EMM
assessment were reported. We included variables for which there is some evidence of EMM in other
environmental determinants of population health and with documented mechanisms leading to a
differential effect. We thus included the following variables: age [42–45], socio-economic factors [39,46],
urbanization level [47,48], smoking status, and other health behaviors (alcohol consumption, diet, and
physical activity) [49,50]. Sex was also included in the review. Socio-economic factors include SES
variables such as education and occupation, as well as indexes that were used in the studies selected.
3. Results
3.1. Description of Studies Selected
The abstracts of 226 articles were assessed, and 26 articles were retained for in-depth review after
applying the first stage of exclusion criteria. Nine articles were added after screening the references
of selected papers. Finally, 19 scientific articles were retained following the second stage exclusion
criteria (Figure 1).
Table 1 summarizes the studies that provide a measure of the cancer risk associated with exposure
to disinfection by-products through drinking water.
Eleven studies were conducted in North America, six in Europe, and two in Asia (Taiwan). The
studies were published between 1981 and 2010. The majority of studies focus on bladder cancer
(n = 14), followed by colon cancer (n = 4) and rectal cancer (n = 5). All are case-control studies, with
the exception of Wilkins and Comsock, [51] and Koivusalo et al., [52] which are cohort studies. The
majority of studies use values of THMs issued from field measurements (n = 10) or modeling (n = 3)
to assess the exposure. The remaining ones use presence or absence of chlorinated water (n = 4) or
the level of mutagenicity of waters (n = 2) as a marker of exposure to DBPs. THMs cut-offs varied
between studies, because the exposure was calculated differently. Studies use long term (>30 years),
fixed [53,54], or variable duration of exposure [55,56], although the majority use fixed levels (but
different values) of DBPs [57–62]. The association between exposure and health issues is almost always
assessed using logistic regression, with Odds Ratios (OR) or Risks Ratios (RR) being reported.
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Figure 1. Flowchart of the selection of studies.
Odds Ratios in the studies selected are between 1.20 and 2.99 for bladder cancer, 0.90 and 1.66
for colon cancer, and 1.01 and 1.68 for rectal cancer (for OR calculated on the whole population
under study). Fourteen studies found a significant relationship with cancer [52,53,55,57–60,62–68].
Five studies did not find a significant relationship between exposure to chlorinated water/DBPs and
cancer, four of which studied bladder cancer [51,54,56,61] and one which studied colon cancer [69].
The majority of studies considered the exposure to THMs as a group of compounds without assessing
the effects of the different compounds. Only the studies of Bove et al. [59,63] considered different
species of THMs (chloroform, bromoform, bromodichloromethane, and chlorodibromomethane) in
their analysis.
Approximately half of the studies assess EMM (n = 10), but the majority of them estimate it
relative to different sex subgroups (total: n = 8, n = 6 for bladder cancer and n = 2 both for rectal
and colon cancers). Generally, higher ORs and relationships that are more significant were noted
for men when studying bladder and colon cancers. For example, in the study of Cantor et al. [64],
an OR of 1.8 for men compared to an OR of 0.6 for women was found for bladder cancer. For rectal
cancer, the results are contradictory, but the number of studies is too limited (n = 2) to draw any
conclusion relative to sex. For women, only one study, which is also a cohort study [52], noted positive
relationships for bladder and rectal cancer. Moreover, the study of Koivusalo et al. [52] is the only one
that found higher risks for women than men (for the three different types of cancer). The duration of
exposure was associated with an increase in bladder cancer risk for men only [7,64]. Fewer studies
assessed the EMM relative to smoking status (n = 3). Finally, one study assessed EMM considering
gene polymorphisms [62]. Generally, in all studies, the EMM assessment was conducted with stratified
analyses. In the study of King et al. [57], an interaction term between exposure and sex was calculated.
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Table 1. Description of studies included in the review.
(a) Bladder cancer.
Studies Location Year ofPublication Sample Size Study Design Disinfection by-Products Measurement
Subgroups Included
in the Analysis Effect Size and CI
Wilkins and
Comstock [51] Maryland, USA 1981
81 cases and
30,699 controls Cohort Exposure to chlorinated drinking water Sex
All: RR = 2.2 (0.71–9.39); Men: RR = 1.80
(0.80–4.75); Women: RR = 1.60 (0.54–6.32)
Zierler et al. [55] Massachusetts, USA 1988 614 cases and1074 controls Case-control Duration of exposure to chlorinated drinking water n.d. All: OR = 2.7 (1.7–4.3)
McGeehin et al.
[53] Colorado, USA 1993
327 bladder cancer
and 261 other-cancer
controls
Case-control Questionnaire & data for TTHM from site visit ofwater utilities Smoking Status
Non–Smokers: OR = 2.9 (1.2–7.4); Smokers:
OR = 2.1 (1.1–3.8)
King and Marrett
[67] Ontario, Canada 1996
696 cases and
1545 controls Case-control
Questionnaire about source of water. Water source
and chlorination status were provided directly by
treatment plant surveys. TTHMs modelling
n.d. All: OR = 1.66 (1.11–2.51)
Freedman et al.
[54] Maryland, USA 1997
294 cases and
2326 controls Case-control Exposure to chlorinated drinking water Sex, smoking habits
All: OR = 1.4 (0.7–2.9); Men: OR = 2.2
(0.8–5.1); Women: OR = 0.6 (0.2–2.2)
Koivusalo et al.
[52] Finland 1997 621 431 Cohort
Questionnaires. Information on water-pipe
connections, past drinking water quality, and
treatment practices by waterworks was obtained from
administrative registers and municipal waterworks.
The level of mutagenicity was estimated by modelling
Sex All: RR = 1.12 (0.93–1.36); Men: RR = 1.03(0.82–1.28); Women: RR = 1.48 (1.01–2.18)
Cantor et al. [64] Iowa, USA 1998 1123 cases and1983 controls Case-control TTHMs in tap water (measures + estimations) Sex, smoking habits
All: OR = 1.3 (0.9–2.0); Men: OR = 1.8
(1.2–2.7); Women: OR = 0.6 (0.3–1.4)
Koivusalo et al.
[56] Finland 1998
732 cases and
914 controls Case-control
Questionnaires. Information on water-pipe
connections, past drinking water quality, and
treatment practices by waterworks was obtained from
administrative registers and municipal waterworks.
The level of mutagenicity was estimated by modelling
Sex Men: OR = 1.17 (0.87–1.57); Women:OR = 1.14 (0.71–1.82)
Chevrier et al. [58] France 2004 281 cases and272 controls Case-control TTHMs modelling Sex
All: OR = 2.99 (1.1–8.5); Men: OR = 3.73
(1.2–11); Women: OR = 1.55 (0.1–32)
Bove et al. [59] New York, USA 2007 182 cases and385 controls Case-control TTHMs in tap water + water consumption n.d.
THM: OR = 2.34 (1.01–3.66); CLF:
OR = 2.55 (1.25–4.66); BRF: OR = 3.05
(1.51–5.69); BDCM: OR = 2.49 (1.19–4.48)
Chang et al. [60] Taiwan 2007 403 cases and403 controls Case-control TTHMs in tap water n.d. All: OR = 2.11 (1.43–3.11)
Michaud et al. [61] Spain 2007 397 cases and664 controls Case-control
Questionnaire and records searches (including
THM measurements) n.d. All: OR = 2.06 (0.83–5.08)
Villanueva et al.
[68] Spain 2007
1219 cases and
1271 controls Case-control
Questionnaire and records searches (including
THM measurements) Sex
All: OR = 2.10 (1.09, 4.02); Men: OR = 2.53
(1.23, 5.20); Women: OR = 1.50 (0.26, 8.61)
Cantor et al. [62] Spain 2010 680 cases and714 controls Case-control TTHMs in tap water Gene polymorphism All: OR = 1.8 (0.9–3.5)
NB: n.d.: No data; OR: Odds Ratio; RR: Risk Ratio; CLF: Chloroform; BRF: Bromoform; BDCM: Bromodichloromethane; Q1: lowest THM concentrations quartile; Q4: highest THM
concentrations quartile.
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(b) Colon and rectal cancers.
Studies Location Year ofPublication Sample Size Study Design Exposition Measurement Site of Cancer
Subgroups Included
in the Analysis Effect Size and CI
Gottlieb and
Carr [65] Louisiana, USA 1982 546 cases and 534 controls Case-control Exposure to chlorinated drinking water Rectal n.d. All: OR = 1.68 (1.17–2.42)
Koivusalo et al.
[52] Finland 1997 621 431 Cohort
Questionnaires. Information on water-pipe
connections, past drinking water quality, and
treatment practices by waterworks was
obtained from administrative registers and
municipal waterworks. The level of
mutagenicity was estimated by modelling
Colon and rectal Sex
Colon: All: RR = 0.90 (0.77–1.04);
Men: RR = 0.83 (0.66–1.04);
Women: RR = 0.95 (0.78–1.85).
Rectal: All: RR = 1.04 (0.86–1.26);
Men: RR = 0.85 (0.66–1.09);
Women: RR = 1.38 (1.03–1.85).
Hildesheim et al.
[66] Iowa, USA 1998
560 colon cases, 537 rectal
cases, and 1983 controls Case-control TTHMs in tap water Colon and rectal n.d.
Colon: OR = 1.06 (0.7–1.6);
Rectal: OR = 1.66 (1.1–2.6)
King et al. [57] Ontario, Canada 2000 767 colon cases, 661 rectalcases, and 1545 controls Case-control
Questionnaire about source of water. Water
source and chlorination status were provided
directly by treatment plant surveys.
TTHMs modelling
Colon and rectal Sex
Colon: OR = 1.87 (1.15–3.05) for
Men; OR = 0.92 (0.49–1.71) for
Women. Rectal: OR = 0.98
(0.56–1.72) for Men; OR = 0.72
(0.34–1.53) for Women
Bove et al. [63] New York State,USA 2007 128 cases and 253 controls Case-control TTHMs in tap water + water consumption Rectal n.d.
THM4: OR = 1.01 (0.98–1.03);
CLF: OR = 1.00 (0.93–1.09); BRF:
OR = 1.20 (1.05–1.35)
Kuo et al. [69] Taiwan 2009 2195 cases and2195 controls Case-control
Questionnaire & data on TTHM levels in
drinking water in study. Municipalities were
collected from the Taiwan Environmental
Protection Administration
Colon n.d. All: OR = 1.04 (0.89–1.21)
NB: n.d.: No data; OR: Odds Ratio; RR: Risk Ratio; CLF: Chloroform; BRF: Bromoform; BDCM: Bromodichloromethane.
Int. J. Environ. Res. Public Health 2018, 15, 979 8 of 13
3.2. Covariables Collected
Table 2 reports the variables collected that could be used for potential EMM assessment for each
of the selected studies.
Table 2. Co-variables collected in the selected studies (candidates for a potential effect measure
modification assessment).
Study Age Sex Socio-EconomicFactors *
Urbanization
Level Smoking
Other Health
Behaviors
Wilkins and Comstock 1981 [51] X X X X
Gottlieb and Carr 1982 [65] X X
Zierler et al. 1988 [55] X X
McGeehin et al. 1993 [53] X
King and Marrett 1996 [67] X X X X
Freedman et al. 1997 [54] X X X
Koivusalo et al. 1997 [52] X X X X X
Cantor et al. 1998 [64] X X X X
Hildesheim et al. 1998 [66] X X
Koivusalo et al. 1998 [56] X X X X X
King et al. 2000 [57] X X X X
Chevrier et al. 2004 [58] X X X X
Bove et al. 2007 [63] X X X
Bove et al. 2007 [59] X X X
Chang et al. 2007 [60] X X
Michaud et al. 2007 [61] X X X
Villanueva et al. 2007 [68] X X X X X
Kuo et al. 2009 [69] X X X
Cantor et al. 2010 [62] X X X X
* Include education, occupation status, or SES index.
Although EMM is not assessed in the majority of the selected papers, some studies collect
covariables that could be used in the future for an heterogeneity assessment. Information about age is
commonly collected in selected studies (n = 16). Moreover, other individual data such as education
and/or occupation status are collected in some of the studies (n = 11). Others report an SES index
(n = 12). Information about the level of urbanization is also frequently collected (n = 9).
4. Discussion
The majority of studies assessing the relationship between THMs and cancer are case-control
studies that focus on bladder cancer. These studies use exposure data issued from direct measurements
or modelling. The majority of studies found an association between chronic exposure to THMs and
bladder cancer. This review revealed that the majority of studies assessed EMM, but primarily for
the effect of sex. Six studies show that the EMM of sex in the association between exposure to DBPs
and bladder cancer may exist, with a higher effect for men than for women. However, only a very
small number of studies have assessed this effect modification for other cancer sites such as colon and
rectal cancer (n = 2 for both cancers), thus preventing any further conclusion about this parameter.
Sex has been found as a more consistent EMM in bladder cancer, and several mechanisms have been
proposed, as previously mentioned. More precisely, pharmacokinetic models in humans have shown
that the activity of CYP2E1, which plays a role in chloroform metabolism, could be higher in men
than in women [70,71]. The role of sex hormones in the modulation of enzymes that metabolizes
DBPs has also been proposed. Brominated THMs are metabolized through a glutathione conjugation
reaction and several studies have shown that glutathione transferases are regulated by thyroid and sex
hormones [23].
The duration of exposure is also an important factor, as the outcomes are cancers at different
sites with different latencies, and it is associated with an increase in bladder cancer risk for men [7,64].
Despite this, the exposure metrics (duration of exposure and means of exposure assessment) differ
between studies selected. This could influence the results obtained in the different studies selected.
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Furthermore, many epidemiological studies on DBPs collect other covariables in addition to
sex, such as SES, age, urbanization level, and smoking status but without evaluating the EMM.
This information could be used to conduct an EMM assessment in future studies and document
the existence of vulnerability factors in the association between DBPs and risk of cancer (notably,
bladder, colon, and rectal cancers). Of course, EMM assessments should be motivated and rely on
a documented hypothesis. These assessments are particularly useful in targeting populations or
territories that public policies should prioritize to reduce socio-demographic inequalities in cancer
risks from water contaminants exposure. We thus strongly encourage further studies to assess the
role of socio-demographic factors such as SES, age, or urbanization level as potential EMMs in the
relationship between DBPs and cancer risk. It is also important to mention that various methods exist in
the literature that assess EMM, such as the Breslow-Day test, the Wald χ2 test, and the regression-based
test of interaction [72,73].
This review is subject to a number of limitations. We included studies that measured THMs
exposure in a range of different approaches. THMs exposure measurement methods have drastically
evolved in the last decades, but we decided to include older studies, as they can inform one of our aims
to reveal possible EMM in the association between THMs exposure and cancer risk. We added 9 studies
after the screening of references of existing papers. This may be due to some missing keywords (e.g.,
“treated drinking water”) despite the fact that we used similar keywords to other systematic reviews
on this topic. Finally, some papers that have been recently published are not included in our review.
For instance, a case–control study conducted in Spain and Italy by Villanueva et al. [74] assessed the
impact of long-term exposure to THMs on colorectal cancer and found no association, considering the
total population without including any EMM assessment.
The majority of the studies quantitatively include gender as a subgroup analysis, but very few
studies focused on other potentially relevant EMMs such as SES. However, we observed that many
studies included in the review collected standard details on covariates that could be, but often are
not, used as stratifying variables. By doing so, we aim to highlight that EMM assessments are easily
feasible in future studies using data that is already collected. We hope that this assessment will
encourage future studies that will assess which populations are more vulnerable to the impacts of
THMs exposure.
Studies on EMM are important to improve public health interventions and better estimate
the potential benefits of an intervention (or its public health impact). For instance, within a large
community/municipality that is supplied by a unique water treatment plant, inequalities in DBP
exposure can be associated with the geographical location of deprived population groups within the
municipality, living in neighborhoods or sectors with relatively high concentration of DBPs in drinking
water (explained by variable residence time of water in the distribution network, pipe material, age and
maintenance, or plumbing systems characteristics). In these cases, local interventions can reduce DBP
exposure and could include two dimensions: (i) infrastructure: for instance, the renewal of distribution
system pipes locally, including plumbing systems, the improving of the local hydraulic management
of the system to reduce stagnation of water, or a better management of booster disinfection; and
(ii) promoting awareness campaigns directed at deprived population concerning the exposure to DBPs
through tap water and other domestic water uses as bath and showering (for example, the adequate
use of domestic equipment to reduce DBPs, such as domestic water filtering, boiling, and refrigeration).
5. Conclusions
Inequalities in cancer incidence according to socio-demographic characteristics [75–77] or location
(ex: rural areas compared to urban areas) have been highlighted in the literature. The role of
environmental exposures such as drinking water contaminants can play an important role in
such disparities. However, the documentation of EMM evidence is still lacking. We therefore
strongly recommend greater use of subgroup analysis when possible, which will provide a greater
understanding of which populations or territories are more vulnerable to the impacts of DBPs.
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